Peer Review History

Original SubmissionAugust 27, 2021
Decision Letter - Scott M. Williams, Editor, Xiaofeng Zhu, Editor

Dear Dr Gillespie,

Thank you very much for submitting your Research Article entitled 'Determining the stability of genome-wide factors in BMI between ages 40 to 69 years.' to PLOS Genetics.

The manuscript was fully evaluated at the editorial level and by independent peer reviewers. The reviewers appreciated the attention to an important problem, but raised some substantial concerns about the current manuscript. Based on the reviews, we will not be able to accept this version of the manuscript, but we would be willing to review a much-revised version. We cannot, of course, promise publication at that time.

Because many readers may not be familiar with gSEMs, we would like to see a rewritten method  with more elucidation. Additional analyses as suggested by reviewer 2 should be included.

Should you decide to revise the manuscript for further consideration here, your revisions should address the specific points made by each reviewer. We will also require a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript. 

If you decide to revise the manuscript for further consideration at PLOS Genetics, please aim to resubmit within the next 60 days, unless it will take extra time to address the concerns of the reviewers, in which case we would appreciate an expected resubmission date by email to plosgenetics@plos.org.

If present, accompanying reviewer attachments are included with this email; please notify the journal office if any appear to be missing. They will also be available for download from the link below. You can use this link to log into the system when you are ready to submit a revised version, having first consulted our Submission Checklist.

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

Please be aware that our data availability policy requires that all numerical data underlying graphs or summary statistics are included with the submission, and you will need to provide this upon resubmission if not already present. In addition, we do not permit the inclusion of phrases such as "data not shown" or "unpublished results" in manuscripts. All points should be backed up by data provided with the submission.

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool.  PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

PLOS has incorporated Similarity Check, powered by iThenticate, into its journal-wide submission system in order to screen submitted content for originality before publication. Each PLOS journal undertakes screening on a proportion of submitted articles. You will be contacted if needed following the screening process.

To resubmit, use the link below and 'Revise Submission' in the 'Submissions Needing Revision' folder.

[LINK]

We are sorry that we cannot be more positive about your manuscript at this stage. Please do not hesitate to contact us if you have any concerns or questions.

Yours sincerely,

Xiaofeng Zhu

Associate Editor

PLOS Genetics

Scott Williams

Section Editor: Natural Variation

PLOS Genetics

Reviewer's Responses to Questions

Comments to the Authors:

Please note here if the review is uploaded as an attachment.

Reviewer #1: Gillespie et al perform a a valuable and insightful structural analysis of age stratified GWAS of BMI, effectively fitting a pseudo longitudinal model to cross sectional data. It is exciting to see GenomicSEM being used in a creative and informative manner.

The results reflect very little novel genetic effects on BMI in older adults in the UKB, this is not unexpected as its generally the age period in which the rank order of BMI in a popualtion across time is more stable than during development or in old age.

Id like too begin the review by mentioning some essential papers that do related things, without undermining the novelty of the current work, but that should be discussed or tied to the current effort.

Here is work using PRS and/or multivariable MR and "BMI" age age 10 and in adulthood (I am not a author on any of these, just all very relevant lit):

Richardson, T. G., Sanderson, E., Elsworth, B., Tilling, K., & Smith, G. D. (2019). Can the impact of childhood adiposity on disease risk be reversed? A Mendelian randomization study. medRxiv, 19008011.

Brandkvist, M., Bjørngaard, J. H., Ødegård, R. A., Åsvold, B. O., Smith, G. D., Brumpton, B., ... & Vie, G. Å. (2020). Separating the genetics of childhood and adult obesity: a validation study of genetic scores for body mass index in adolescence and adulthood in the HUNT Study. Human molecular genetics, 29(24), 3966-3973.

Richardson, T. G., Crouch, D. J., Power, G. M., Berstein, F. M., Hazelwood, E., Fang, S., ... & Smith, G. D. (2021). Disentangling the direct and indirect effects of childhood adiposity on type 1 diabetes and immune-associated diseases: a multivariable Mendelian randomization study. medRxiv.

There is more work on repeatedly measured BMI in MoBa, which also is very relevant.

Hone, L., Jacobs, B. M., Marshall, C. R., Giovannoni, G. R., Noyce, A., & Dobson, R. (2021). Age-specific effects of childhood BMI on multiple sclerosis risk: a Mendelian Randomisation study. medRxiv.

Helgeland, Ø., Vaudel, M., Juliusson, P. B., Holmen, O. L., Juodakis, J., Bacelis, J., ... & Njølstad, P. R. (2019). Genome-wide association study reveals dynamic role of genetic variation in infant and early childhood growth. Nature communications, 10(1), 1-10.

There are more, I feel it exceeds my responsibility as a reviewer to look those up.

With those pre-requisite out of the way, lets get to the paper itself, mayor concerns:

You conclude that: "differences in BMI across age could not be explained by the accumulation of age-specific genetic influences or autoregressive processes" This is true but it would be good to reflect on what, if anything, the genetic model selected based on parsimony would mean for the phenotypic model (if anything). I for one suspect most people would conceptualise causal auto-regressive effects of BMI at the phenotypic level, would your defining challenge such a model under what conditions would it/wouldn't it?

There are actual repeated measured within UKB, 20k people went for a second clinic visit and 46k people went in for an imaging visit. your model makes predictions about the rg we expect to see there it would be good to test those. (I admit I expect very little based on your high rg, which makes for an interesting test, what if these data do not conform?)

There is a further possible source of corroboration you could pursuit, your model implies a certain rg between BMI and change in weight, UKB includes a Q on recent weight change: https://biobank.ndph.ox.ac.uk/showcase/field.cgi?id=2306 and for those pprepeatedly measured you can compute actual weight change.

The final GWAS I listed previously among the literature suggestions has sumstats available, we have been running simple models with those, without a clear goal in mind other than to develop some instructional examples, but you could consider integrating them into this paper into a single model (then age 6 weeks to age 70...), might be beyond the scope of this manuscript. This is actually specifically a point where GenomicSEM would complement full data SEM/gSEM, genomicSEM can go beyond a single cohort, raw data SEM can allow for additional types of models.

The Genome wide model need not hold for individual GWAS hits, can you validate well know BMI loci (FTO etc) effect the age stratified outcomes in a manner consistent with the global model (You could use Q-statistic or inspect the effect sizes for various top hits)

The discussion could use a clearer discussion of the limitation of pseudo longitudonal modeling in general, when do we expect it to fail etc.

Reviewer #2: The authors applied SEMs to evaluate the stability of genome wide determinants of BMI in adult populations. The scientific question is good and clearly explained. While this is a worthwhile investigation, there are a few limitations that may make this manuscript less relevant, as it is, for the wide audience of readers interested in genetics in general.

1. The age range is limited -- only adults. It is not clear that the results is surprising given that. Previous results (Winkler et al) found lower genetic correlation between age groups of less and more than 50. It would be useful to look at younger individuals.

2. The modeling approach using gSEMs. Many researchers are not familiar with that and the specialized nomenclature used make it difficult to assess the methodology. It would be very useful-- and required -- to spell out the statistical model to explain things, e.g., what "innovations" are.

3. Also, it is not clear how the GWAS were used. Only for computing genetic correlations and heritability? (maybe it was clear, I just want to make sure). Then the Lavann software used these to construct and over all covariance matrix?

4. I was expecting to see some results estimating genetic associations of specific variants known to be highly associated with BMI, meaning, to look at their effects over time.

5. I also expected to see PRS associations evaluated over time. The authors can also construct PRS based on each of the GWAS and study associations with different age groups.

**********

Have all data underlying the figures and results presented in the manuscript been provided?

Large-scale datasets should be made available via a public repository as described in the PLOS Genetics data availability policy, and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.

Reviewer #1: No: Please also upload GWAS sumstats to a public repository.

Reviewer #2: None

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Tamar Sofer

Revision 1

Attachments
Attachment
Submitted filename: Response_to_reviewers.docx
Decision Letter - Scott M. Williams, Editor, Xiaofeng Zhu, Editor

Dear Dr Gillespie,

We are pleased to inform you that your manuscript entitled "Determining the stability of genome-wide factors in BMI between ages 40 to 69 years." has been editorially accepted for publication in PLOS Genetics. Congratulations!

Before your submission can be formally accepted and sent to production you will need to complete our formatting changes, which you will receive in a follow up email. Please be aware that it may take several days for you to receive this email; during this time no action is required by you. Please note: the accept date on your published article will reflect the date of this provisional acceptance, but your manuscript will not be scheduled for publication until the required changes have been made.

Once your paper is formally accepted, an uncorrected proof of your manuscript will be published online ahead of the final version, unless you’ve already opted out via the online submission form. If, for any reason, you do not want an earlier version of your manuscript published online or are unsure if you have already indicated as such, please let the journal staff know immediately at plosgenetics@plos.org.

In the meantime, please log into Editorial Manager at https://www.editorialmanager.com/pgenetics/, click the "Update My Information" link at the top of the page, and update your user information to ensure an efficient production and billing process. Note that PLOS requires an ORCID iD for all corresponding authors. Therefore, please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field.  This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager.

If you have a press-related query, or would like to know about making your underlying data available (as you will be aware, this is required for publication), please see the end of this email. If your institution or institutions have a press office, please notify them about your upcoming article at this point, to enable them to help maximise its impact. Inform journal staff as soon as possible if you are preparing a press release for your article and need a publication date.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Genetics!

Yours sincerely,

Xiaofeng Zhu

Section Editor: Methods

PLOS Genetics

Scott Williams

Section Editor: Human Variation

PLOS Genetics

www.plosgenetics.org

Twitter: @PLOSGenetics

----------------------------------------------------

Comments from the reviewers (if applicable):

Reviewer's Responses to Questions

Comments to the Authors:

Please note here if the review is uploaded as an attachment.

Reviewer #1: My comments were addressed, pseudo longitudinal modeling is an exciting potential application of genomicSEM.

Reviewer #2: Thank you for responding to the earlier comments, I have no further comments. Nice work!

**********

Have all data underlying the figures and results presented in the manuscript been provided?

Large-scale datasets should be made available via a public repository as described in the PLOS Genetics data availability policy, and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.

Reviewer #1: No: The underlying data is restricted access for good reasons (genotypes privacy etc etc). Qualified researchers in academia and industry can obtain access to the underlying raw data.

Reviewer #2: None

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

----------------------------------------------------

Data Deposition

If you have submitted a Research Article or Front Matter that has associated data that are not suitable for deposition in a subject-specific public repository (such as GenBank or ArrayExpress), one way to make that data available is to deposit it in the Dryad Digital Repository. As you may recall, we ask all authors to agree to make data available; this is one way to achieve that. A full list of recommended repositories can be found on our website.

The following link will take you to the Dryad record for your article, so you won't have to re‐enter its bibliographic information, and can upload your files directly: 

http://datadryad.org/submit?journalID=pgenetics&manu=PGENETICS-D-21-01158R1

More information about depositing data in Dryad is available at http://www.datadryad.org/depositing. If you experience any difficulties in submitting your data, please contact help@datadryad.org for support.

Additionally, please be aware that our data availability policy requires that all numerical data underlying display items are included with the submission, and you will need to provide this before we can formally accept your manuscript, if not already present.

----------------------------------------------------

Press Queries

If you or your institution will be preparing press materials for this manuscript, or if you need to know your paper's publication date for media purposes, please inform the journal staff as soon as possible so that your submission can be scheduled accordingly. Your manuscript will remain under a strict press embargo until the publication date and time. This means an early version of your manuscript will not be published ahead of your final version. PLOS Genetics may also choose to issue a press release for your article. If there's anything the journal should know or you'd like more information, please get in touch via plosgenetics@plos.org.

Formally Accepted
Acceptance Letter - Scott M. Williams, Editor, Xiaofeng Zhu, Editor

PGENETICS-D-21-01158R1

Determining the stability of genome-wide factors in BMI between ages 40 to 69 years.

Dear Dr Gillespie,

We are pleased to inform you that your manuscript entitled "Determining the stability of genome-wide factors in BMI between ages 40 to 69 years." has been formally accepted for publication in PLOS Genetics! Your manuscript is now with our production department and you will be notified of the publication date in due course.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript.

Soon after your final files are uploaded, unless you have opted out or your manuscript is a front-matter piece, the early version of your manuscript will be published online. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting PLOS Genetics and open-access publishing. We are looking forward to publishing your work!

With kind regards,

Zsofi Zombor

PLOS Genetics

On behalf of:

The PLOS Genetics Team

Carlyle House, Carlyle Road, Cambridge CB4 3DN | United Kingdom

plosgenetics@plos.org | +44 (0) 1223-442823

plosgenetics.org | Twitter: @PLOSGenetics

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .